11/08/2007

D-tek S.A.

New BlueDot APS for screening of Anti-Phospholipid Syndrome

The Antiphospholipid syndrome (APS) is a disorder of coagulation defined by the presence of antiphospholipid antibodies in patients with recurrent venous or arterial thrombosis, thrombocytopenia and pregnancy-related complications.
APS can occur in patients without evidence of any definable associated disease or in association with SLE, another autoimmune disease. Traditionally, this has been referred to as Primary APS or Secondary APS respectively.

Anti-phospholipid antibodies bind to anionic phospholipids, especially the Cardiolipin/Beta2-Glycoprotein complex and/or Beta2-Glycoprotein alone.

In this context, D-tek has developped a new BlueDot APS that allows to screen serologically for the anti-Phospholipid Syndrome.


For more information, please visit www.d-tek.be